ALK AG has a total of 26 patent applications. Its first patent ever was published in 2010. It filed its patents most often in China, EPO (European Patent Office) and Brazil. Its main competitors in its focus markets pharmaceuticals and control are NALPROPION PHARMACEUTICALS LLC, LI ZELIN and OREXIGEN THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 4 | |
#2 | EPO (European Patent Office) | 4 | |
#3 | Brazil | 3 | |
#4 | Canada | 3 | |
#5 | Republic of Korea | 3 | |
#6 | Mexico | 3 | |
#7 | WIPO (World Intellectual Property Organization) | 3 | |
#8 | Hong Kong | 2 | |
#9 | Australia | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Control |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Teaching materials |
# | Name | Total Patents |
---|---|---|
#1 | Baillie Alan J | 17 |
#2 | Macdonald Kenneth | 15 |
#3 | Porteous Pamela | 15 |
#4 | Hendry Simon | 15 |
#5 | Groves Bryce Vernon | 9 |
#6 | Coady Gareth Michael | 9 |
#7 | Yeates Henry Samuel | 9 |
#8 | Lombardelli Stephen | 8 |
#9 | Kenneth Macdonald | 2 |
#10 | Simon Hendry | 2 |
Publication | Filing date | Title |
---|---|---|
EP2727100A1 | A method, a device and a computer program product for training the use of an auto-injector | |
HK1162975A1 | Stabilised composition comprising at least one adrenergic compound | |
EP2541532A1 | A training device for an auto-injector | |
CN102497882A | Stabilised composition comprising at least one adrenergic compound |